FDA Approved: * September 28, 2004 Pharm Company: *BEDFORD Category:Cancer
Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.
4 External links
Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines, such as daunorubicin or doxorubicin or other c...
* May have multiple approval dates, manufacturers, or labelers.
Dexrazoxane 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution